Why drug repurposing strategies reduce risk

Fiercebiotech.com

Klicken Sie hier, um Fiercebiotech.com zu abonnieren

Laden...

3 jahre vor

Html
Text

Download Whitepaper

This week's Fierce Biotech is brought to you by ThermoFisher Scientific.
Trouble viewing? Click here.

WHITEPAPER
Drug repurposing trends and strategic approaches for shortening timelines

Download Whitepaper

Drug repurposing constitutes anywhere from 10% to 50% of the current R&D spending and is a determining factor in the life cycle management of pharmaceutical products. Repurposing drug candidates are known for their safety, cost savings, and commercial benefits. Download this white paper to learn more about:

The drug repurposing development pathway Low-risk and cost-effective strategies Case study examples on bringing molecules to market faster

Download Whitepaper

Thermo Fisher Scientific, 4815 Emperor Blvd., Durham, NC 27703-8470, USA | +1 919-226-3200
thermofisher.com/patheon | [email protected] | Privacy Information Center
© 2021 Thermo Fisher Scientific Inc. All Rights Reserved.

If you no longer wish to receive communications from ThermoFisher Scientific, please opt out here.

Want to reach 137,000+ Fierce Biotech subscribers with your own message?
Contact [email protected] or call 202-824-5074.

You are currently subscribed as [email protected].
If you no longer wish to receive communications from Fierce Biotech's trusted partners, simply click here to unsubscribe.
Refer to our Privacy Policy.

Why drug repurposing strategies reduce risk

Teilen auf

Weitere Newsletter von Fiercebiotech.com

Verwandte Newsletter